GenesisCare - logo
Enquire now
Refer a patient

Your state: AU |

down arrow down arrow

Breast Cancer

Breast Cancer
2025-06-03T00:00:00.000+10:00
Ongoing

Destiny-Breast15

Destiny-Breast15
Prostate

A phase 3b global open label study of T-Dxd in subjects who have unresectable or metastatic HER2 low or HER2 IHC Breast Cancer

A phase 3b global open label study of T-Dxd in subjects who have unresectable or metastatic HER2 low or HER2 IHC Breast Cancer

Trial overview

Clinical Area

Medical Oncology

Disease

Breast

Disease site

Breast

Study Phase

III

Trial Identifiers

Registration number: NCT05950945

https://clinicaltrials.gov/study/NCT05950945

GenesisCare Location(s)
Principal Investigator(s)
Medical Oncologist

A/Prof Nick Murray

BM MS MA DPhil FRCP(Lon) FRACP

A/Prof Nick Murray
Nick
Murray
View Profile
Profile Image - A/Prof Nick Murray

Clinical trials enquiries

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.


 

Disclaimer:

This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.

You are leaving our website

You are now leaving our website. GenesisCare do not control this content and therefore are not responsible for its accuracy or reliability.